title: Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid.
abstract: Free oxyradicals are involved in the signal transduction of ischemic preconditioning in rats and rabbits. Data from larger mammals in which the infarct development is closer to that in humans are lacking. We have therefore investigated the impact of the radical scavenger ascorbic acid on ischemic preconditioning in pigs. In 33 anesthetized pigs, the left anterior descending coronary artery was perfused from an extracorporeal circuit. Infarct size (measured as percent area at risk) was determined by triphenyltetrazolium chloride staining. In placebo-treated animals undergoing 90 min of severe ischemia and 120 min of reperfusion, infarct size averaged 26.9 +/- 3.9% (mean +/- SE; n = 9). Ischemic preconditioning by 10 min of ischemia and 15 min of reperfusion reduced infarct size to 6.4 +/- 2.4% (P < 0.05 vs. placebo; n = 9). Intravenous infusion of ascorbic acid (30 min before ischemic preconditioning or ischemia; 2-g bolus followed by 25 mg/min until the end of ischemia) had no effect on infarct size per se (22.6 +/- 6.5%; n = 6), but largely abolished the infarct size reduction by ischemic preconditioning (19.1 +/- 5.4%; n = 9). Scavenging of free oxyradicals with ascorbic acid largely attenuates the beneficial effect of ischemic preconditioning in pigs.
authors.affiliation: Institute of Pathophysiology, Center of Internal Medicine, University of Essen Medical School, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Skyschally
authors.forename: Rainer
authors.initials: R
authors.lastname: Schulz
authors.forename: Petra
authors.initials: P
authors.lastname: Gres
authors.forename: Hans-Gert
authors.initials: HG
authors.lastname: Korth
authors.forename: Gerd
authors.initials: G
authors.lastname: Heusch
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004334:Drug Administration Schedule; D005260:Female; D007262:Infusions, Intravenous; D019157:Ischemic Preconditioning, Myocardial; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology*; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors*; D013552:Swine; D013556:Swine, Miniature
chemical_list: D000975:Antioxidants; D017382:Reactive Oxygen Species; D001205:Ascorbic Acid